Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer

被引:0
|
作者
Narwariya, Abhinav [1 ]
Dhakar, Mhendr [2 ]
Jatav, Jagannath [3 ]
Prajapati, Raju [4 ]
Bayer, Sujata [5 ]
Moosa, Shajiya Sarwar [5 ]
Shaikh, Mohammad Habeebur Raheman [5 ]
Ali, Mohammed Taher [6 ]
Ahmad, Arafat [7 ]
Begum, Yousuf [5 ]
Hiware, Sanket D. [5 ]
机构
[1] Apollo Hosp, Med Oncol, New Delhi, India
[2] All India Inst Med Sci, Radiat Oncol, Raipur, India
[3] Shyam Shah Med Coll & Sanjay Gandhi Mem Hosp, Pathol, Rewa, India
[4] Shyam Shah Med Coll & Sanjay Gandhi Mem Hosp, Radiat Oncol, Rewa, India
[5] Imam Abdulrahman Bin Faisal Univ, Anat, Dammam, Saudi Arabia
[6] Imam Abdulrahman Bin Faisal Univ, Clin Pharmacol, Dammam, Saudi Arabia
[7] Imam Abdulrahman Bin Faisal Univ, Biochem, Dammam, Saudi Arabia
关键词
breast cancer radiotherapy; hypofractionation; lumpectomy; mastectomy; conventional radiotherapy; RADIATION-THERAPY; WOMEN; RISK;
D O I
10.7759/cureus.29147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Breast cancer is the most commonly diagnosed cancer causing death among females worldwide. Radiotherapy after lumpectomy/mastectomy in breast cancer cases is a successful treatment modality taking five weeks to complete. The aim of the present study is to compare the effectiveness of hypo-fractionated radiotherapy in breast cancer patients with conventional radiotherapy with respect to outcome and toxicity.Methods: Sixty patients were randomly divided equally into a conventional group, Group A (dose: 50 Gy in 25 fractions), and a hypo-fractionated short-course radiotherapy group, Group B (dose: 40 Gy in 16 fractions). After thorough clinical and laboratory examination of all patients, the disease status was assessed prior to radiotherapy and three and six months after completion of radiotherapy. The cardiopulmonary function was assessed using echocardiography and pulmonary function tests prior to the procedure. The assessment of the development of toxicity (dysphagia, skin, lung, and lymphedema) was done during every clinical visit.Results: The mean age of patients was 53.28 +/- 9.73 years in Group A, and 55.67 +/- 10.41 years in Group B (p=0.82). The right breast was involved in 13 (43.4%) patients in Group A and 14 (46.6%) in Group B, and the left breast was involved n 17 (56.6%) patients in Group A and 16 (53.4%) in Group B (p=0.81). Most of the patients were post-menopausal; 24 (80%) in Group A and 25 (83.4%) in Group B (p=0.91). Eleven (36.6%) patients were of stage T2N1M0 in both groups. However, no statistical difference was observed between the groups in the TNM (tumor, node, and metastasis) staging using the AJCC (American Joint Committee on Cancer) criteria (p=0.26). On comparing the responses in Group A and Group B, no significant difference was observed in either of the groups from immediate post-treatment to the 12-month follow-up period (p=0.53 and p=0.64, respectively).Conclusion: Hypo-fractionated radiotherapy is as effective as conventional radiotherapy and can be used as an alternative method for treatment following breast cancer surgery.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Hypo-Fractionated Intensity Modulated Radiotherapy (IMRT) After Prostatectomy: Results Of A Prospective Study
    Qin, S.
    Gao, X.
    Li, H.
    Li, X.
    Qi, X.
    Wang, R.
    Ma, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E873 - E873
  • [32] Intensity Modulated Radiotherapy (IMRT) after Prostatectomy: Acute Toxicity Comparison of Conventional Versus Moderately Hypo-Fractionated Radiation Regimens
    Qin, S. B.
    Gao, X. S.
    Li, H. Z.
    Li, X.
    Qi, X.
    Ma, M. W.
    Wang, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E304 - E304
  • [33] Central hepatobiliary toxicity after liver SBRT and hypo-fractionated Radiotherapy
    Gkika, E.
    Weis, C.
    Kirste, S.
    Mohammad, F.
    Adebahr, S.
    Baltas, D.
    Brunner, T.
    Grosu, A. L.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S551 - S551
  • [34] Hypo-Fractionated Intensity Modulated Radiotherapy (IMRT) After Prostatectomy: Results of a Prospective Study
    Qin, S. B.
    Gao, X. S.
    Li, H. Z.
    Li, X. Y.
    Qi, X.
    Ma, M. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E291 - E291
  • [35] Implementation of adaptive radiotherapy in a phase III randomized trial comparing hypo-fractionated treatment with conventional fractionated treatment of intermediate risk prostate cancer
    Pos, F.
    Nijkamp, J.
    Remeijer, P.
    Sonke, J.
    van Herk, M.
    Lebesque, J.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S111 - S112
  • [36] INTRABEAM: precision hypo-fractionated radiotherapy with a systemic immune response.
    Linares, I.
    Berenguer, M. A.
    Martinez, E.
    Laplana, M.
    Canas, R.
    Comas, S.
    Perez-Montero, H.
    Ventura, M.
    Guedea, F.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S596 - S596
  • [37] CLINICAL PROGRESS AND SURVIVAL OF PATIENTS WITH GLIOBLASTOMA AFTER HYPO-FRACTIONATED RADIOTHERAPY
    Jakes, A. D.
    Boyer, M.
    Hatfield, P.
    NEURO-ONCOLOGY, 2014, 16
  • [38] Hypofractionated Versus Conventional Fractionated Radiotherapy for Reconstructed Breast Cancer: Toxicity Analysis
    Kim, D. Y.
    Park, E.
    Heo, C. Y.
    Kim, E. K.
    Kim, I. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E21 - E21
  • [39] HYPO-FRACTIONATED INTENSITY MODULATED RADIOTHERAPY IN DEFINITIVE TREATMENT OF PROSTATE CANCER: A REPORT OF ACUTE TOXICITY
    Della Bosca, Elisa
    Motta, Micaela
    Ravasio, Andrea
    Di Rienzo, Luigi
    Pedrini, Chiara
    Locatelli, Federica
    Pierelli, Alessio
    Vai, Alessandro
    Salmoiraghi, Paolo
    Vavassori, Vittorio
    ANTICANCER RESEARCH, 2014, 34 (05) : 2606 - 2607
  • [40] The response of portal vein tumoral thrombosis to moderately hypo-fractionated radiotherapy using intensity modulated radiotherapy
    Abdel-Azeez, A.
    Saber, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S607 - S607